{"Title": ["Better Coronavirus Stock: Grifols or Novartis?", "Who Can Donate Plasma for COVID-19 Patients?", "7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains", "BBH's Underlying Holdings Could Mean 11% Gain Potential", "Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing", "Analysts Anticipate 24% Gains Ahead For The Holdings of BBH", "Interesting GRFS Put And Call Options For November 20th", "2 Biotechs Battling Immune Diseases", "Better Coronavirus Stock: Grifols or Novartis?", "Is Rigel Pharmaceuticals Stock a Buy?", "Grifols, S.A. (GRFS) Ex-Dividend Date Scheduled for December 02, 2019", "Keep An Eye On GRFS, FIVN, INGN\u2026", "Interesting GRFS Put And Call Options For May 2020", "Grifols SA, Barcelona is Now Oversold (GRFS)", "Interesting GRFS Put And Call Options For September 20th", "Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN", "Here's Why Rigel Pharmaceuticals Is Erupting This Week", "After Hours Most Active for Apr 17, 2019 : VEON, XOG, VNET, GRFS, QCOM, INTC", "European ADRs Move Lower in Wednesday Trading", "Here's Why Rigel Pharmaceuticals Gained 17.3% in March", "European ADRs Move Higher in Tuesday Trading", "Here's Why Rigel Pharmaceuticals Gained 17.3% in March", "European ADRs Move Higher in Friday Trading", "European ADRs Move Lower in Monday Trading", "Health Care Sector Update for 04/22/2019: ENZ,HOLX,GRFS,TNXP,MBRX,ISRG", "European ADRs Move Lower in Thursday Trading", "European ADRs Move Lower in Thursday Trading", "European ADRs Move Sharply Higher in Friday Trading", "European ADRs Move Lower in Thursday Trading", "European ADRs Move Higher in Tuesday Trading", "After Hours Most Active for Nov 6, 2018 : GRFS, F, LHO, FDC, RF, GE, QQQ, BAC, SBUX, SIRI, NUAN, COMM", "European ADRs Move Higher in Monday Trading", "European ADRs Move Lower in Thursday Trading", "European ADRs Move Lower in Thursday Trading", "Grifols (GRFS) Surges: Stock Moves 5.4% Higher", "European ADRs Edge Lower in Thursday Trading", "European ADRs Move Lower in Thursday Trading", "European ADRs Move Higher in Wednesday Trading", "Is Grifols, S.A. (GRFS) a Great Stock for Value Investors?", "European ADRs Move Lower in Thursday Trading", "European ADRs Move Lower in Friday Trading", "How The Pieces Add Up: BBH Headed For $146", "European ADRs Move Lower in Wednesday Trading", "2 Stable and 2 Speculative Biotech Stocks to Buy", "European ADRs Move Higher in Monday Trading", "3Pea Is A Payment Processor With >40% Organic Growth Selling For Half Of Peer Multiples", "European ADRs Move Sharply Lower in Thursday Trading", "European ADRs Move Higher in Wednesday Trading", "European ADRs Move Lower in Wednesday Trading", "Grifols SA, Barcelona (GRFS) Shares Cross Below 200 DMA", "European ADRs Move Higher in Wednesday Trading", "Stocks With Rising Relative Strength: Novartis", "AstraZeneca Gets Relative Strength Rating Upgrade", "Stocks Showing Improving Market Leadership: Grifols Earns 82 RS Rating", "FBT, NBIX, GRFS, ILMN: ETF Inflow Alert", "Earnings Season Watch List: AbbVie", "Henry Schien to Distribute Grifols Product in United States", "Valeant Pharmaceuticals Joins Elite Club Of Stocks With RS Ratings Over 90", "Valeant Pharmaceuticals Shows Rising Price Performance With Jump To 83 RS Rating", "Valeant Pharmaceuticals Shows Rising Relative Price Performance; Still Shy Of Key Threshold", "Valeant Pharmaceuticals Earns Technical Rating Upgrade", "AstraZeneca Getting Closer To Key Technical Benchmark", "European ADRs Edge Lower as Pharmaceutical Stocks See Mixed Fortunes", "First Week of August 17th Options Trading For Grifols SA", "European ADRs Edge Higher as Manufacturers Gain Traction", "Stocks Showing Rising Market Leadership: Grifols Earns 83 RS Rating", "Stocks With Rising Relative Strength: AstraZeneca", "Gladstone Capital Management LLP Buys Match Group Inc, Bank of New York Mellon Corp, Hertz ...", "Should Value Investors Consider Grifols (GRFS) Stock Now?", "3 Pharma/Biotech Sector Bargains for a Healthy Portfolio", "European ADRs Advance as Pharma Stocks See Mixed Fortunes", "European ADRs Edge Lower as Miners, Telecommunications Stocks See Mixed Fortunes", "European ADRs Fractionally Higher as Banks See Mixed Fortunes", "Gladstone Capital Management LLP Buys Activision Blizzard Inc, Charter Communications Inc, ...", "Interesting GRFS Put And Call Options For February 2018", "European ADRs Move Higher in Friday Trading", "Should Value Investors Consider Grifols (GRFS) Stock Right Now?", "Tuesday's ETF Movers: VGK, IHF", "VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y", "European ADRs Move Lower in Wednesday Trading", "European ADRs Fractionally Higher as Banks See Mixed Fortunes", "Gladstone Capital Management LLP Buys Activision Blizzard Inc, Charter Communications Inc, ...", "Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View", "AbbVie (ABBV) Presents Positive Data on HCV Combination Drug", "Nivalis' (NVLS) Shares Down After Merger Deal with Alpine", "Zacks.com featured highlights: Arbor Realty, Commercial Vehicle Group, Grifols, S.A., Match Group and Xcerra", "GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1%", "European ADRs Fractionally Higher as Banking Stocks Edge Forward", "AMAG Files for FDA Approval of Subcutaneous Form of Makena", "Ohr Pharmaceutical (OHRP) Jumps: Stock Adds 15% in Session", "Infinity Pharmaceuticals (INFI) Looks Good: Stock Jumps 19%", "TherapeuticsMD Falls on Likely Delay in TX-004HR Approval", "Wednesday's ETF Movers: FBT, XME", "Galectin Therapeutics (GALT) Looks Good: Stock Jumps 16.7%", "Amgen Files for Xgeva Label Expansion, To Include Myeloma", "How to Uncover Institutional Buying", "New Breakout Stocks Zacks Rank #1 (Strong Buy)", "European ADRs Edge Lower as Pharmaceutical Stocks See Mixed Fortunes", "AbbVie's (ABBV) Humira Drug Label Update Approved by FDA", "New Strong Buy Stocks for March 30th", "Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%", "5 Cheap PEG Picks for Value Investors Right Now", "Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod", "Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk", "New Breakout Stocks Zacks Rank #1 (Strong Buy)", "European ADRs Edge Lower as Pharmaceutical Stocks See Mixed Fortunes", "AbbVie's (ABBV) Humira Drug Label Update Approved by FDA", "New Strong Buy Stocks for March 30th", "Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%", "5 Cheap PEG Picks for Value Investors Right Now", "Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod", "AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal", "European ADRs Fractionally Higher as Health Care Stocks See Mixed Fortunes", "Is Grifols a Great Stock for Value Investors?", "Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session", "New Strong Buy Stocks for March 9th", "Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%", "Pre-Market Earnings Report for February 29, 2016 : VRX, ENDP, IEP, NRG, HZNP, TRCO, VGR, ACAD, GRFS, BCPC, FI, SJI", "Hologic (HOLX) to Divest Blood Screening Business to Grifols", "European ADRs Advance as Pharmaceutical Firms Strengthen", "FBT, CRL, QGEN, GRFS: Large Outflows Detected at ETF", "Pre-Market Most Active for Dec 2, 2015 : VALE, YHOO, CPGX, ABEV, ZFGN, SUNE, BAC, XOM, AMSG, TVIX, XIV, GRFS", "Grifols (GRFS): Moving Average Crossover Alert", "Noteworthy ETF Outflows: FBT, MYGN, NKTR, GRFS", "GRFS Makes Bullish Cross Above Critical Moving Average", "European ADRs Advance as Mining Stocks Extend Gains", "First Trust NYSE Arca Biotechnology Index Fund Experiences Big Outflow", "European ADRs Gain as Manufacturing Activity Rises in Eurozone", "European ADRs Flat as Pharma Gains Are Outweighed By Mining Losses", "European ADRs Higher as Oil Producers and Pharma Stocks Rise", "European ADRs Trade Higher as Eurozone Growth Forecast Rises", "Zacks Rank #5 Additions for Tuesday - Tale of the Tape", "Grifols, S.A. (GRFS) Ex-Dividend Date Scheduled for December 04, 2014", "European ADRs Decline, Dragged Down By Oil, Pharmaceuticals", "European ADRs Fractionally Higher as Pharmaceuticals Stocks Gain", "Grifols (GRFS) Shares Cross Above 200 DMA", "Markets end July undecided", "GRFS Crosses Below Key Moving Average Level", "Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Positive Phase IIb Data from Jazz Pharma - Analyst Blog", "Grifols, S.A. (GRFS) Ex-Dividend Date Scheduled for June 05, 2014", "European ADRs Pulled down by Contractions in Pharmaceutical Stocks", "Grifols (GRFS) Shares Cross Above 200 DMA", "Markets end July undecided", "GRFS Crosses Below Key Moving Average Level", "Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% - Tale of the Tape", "Pharmacyclics (PCYC) Crumbles: Stock Falls by 7.7% - Tale of the Tape", "PharmAthene (PIP) Crumbles: Stock Falls by 7.1% - Tale of the Tape", "Patients Enrolled in Avanir Study - Analyst Blog", "Pipeline Update from Avanir - Analyst Blog", "Zacks Rank #1 Additions for Wednesday - Tale of the Tape", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "New Analyst Coverage - Screen of the Week", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Ariad Pharmaceuticals (ARIA) Surges: Stock Moves 12.1% Higher - Tale of the Tape", "Anacor Pharmaceuticals (ANAC) Jumps: Stock Rises 9.4% - Tale of the Tape", "Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape", "Would You Fix Europe? - Real Time Insight", "Can Grifols (GRFS) Stock Continue to Grow Earnings? - Tale of the Tape", "Flamel Technologies SA (FLML) Jumps: Stock Adds 8.7% - Tale of the Tape", "John Paulson's Top Five Holdings", "Pre-Market Most Active for Nov 14, 2013 : CSCO, KSS, QQQ, SAN, FB, ALU, MFG, CDW, RDS/B, SIRI, ABX, GRFS", "John Paulson Buys Vodafone, Time Warner Cable, Family Dollar Stores, Sells Sprint, Pioneer ...", "Forest Labs Impresses with Earnings Beat, View Up - Analyst Blog", "ARIAD's Iclusig Returns to U.S. - Analyst Blog", "Would You Fix Europe? - Real Time Insight", "Can Grifols (GRFS) Stock Continue to Grow Earnings? - Tale of the Tape", "Flamel Technologies SA (FLML) Jumps: Stock Adds 8.7% - Tale of the Tape", "Aradigm, Grifols Collaborate - Analyst Blog", "Pre-Market Most Active for Jun 12, 2013 : CTB, NCT, WDAY, BAC, VOD, S, NOK, GT, GRFS, ARNA, SIRI, CLVS", "Mid-Day Market Update: Gogo Jumps On Upbeat Results; 8x8 Shares Tumble", "Grifols, S.A. (GRFS) Ex-Dividend Date Scheduled for May 29, 2013", "After Hours Most Active for May 8, 2013 : MAC, QQQ, GRPN, MRK, GMCR, DDD, MU, COR, GRFS, ETP, CX, GT", "Zacks Rank #5 Additions for Thursday - Tale of the Tape", "Pre-Market Most Active for Mar 19, 2013 : BAC, NOK, ERIC, TWO, CHL, GRFS, LULU, HPT, SIRI, DELL, HNR, QQQ", "Pre-Market Most Active for Nov 1, 2012 : JDAS, SIRI, BAC, NOK, CBB, SNY, PHG, GRFS, PFE, AAPL, ASML, QQQ", "Pre-Market Most Active for May 29, 2012 : VRTX, BAC, NOK, LCRY, FB, GNOM, STD, BHP, GRFS, AMRN, BUD, C", "Pre-Market Most Active for May 9, 2012 : BAC, ARNA, ARMH, NOK, SODA, GRFS, QQQ, RDS/B, IHG, F, C, KTOS", "Pre-Market Most Active for Jun 4, 2013 : ET, ING, NOK, ZNGA, ASML, BAC, UBS, MTU, RIGL, GRFS, QQQ, INFI"], "Elapsed Time": ["JUN 19, 2020", "JUN 14, 2020", "JUN 9, 2020", "JUN 8, 2020", "APR 7, 2020", "APR 6, 2020", "MAR 27, 2020", "JAN 19, 2020", "JUN 19, 2020", "DEC 11, 2019", "NOV 29, 2019", "NOV 6, 2019", "SEP 26, 2019", "SEP 9, 2019", "JUL 23, 2019", "JUL 5, 2019", "JAN 16, 2020", "APR 17, 2019", "APR 10, 2019", "APR 9, 2019", "APR 9, 2019", "APR 9, 2019", "MAR 29, 2019", "MAR 25, 2019", "APR 22, 2019", "FEB 7, 2019", "JAN 17, 2019", "JAN 4, 2019", "DEC 6, 2018", "NOV 13, 2018", "NOV 6, 2018", "OCT 29, 2018", "MAR 7, 2019", "FEB 7, 2019", "OCT 12, 2018", "OCT 11, 2018", "OCT 4, 2018", "OCT 3, 2018", "SEP 17, 2018", "AUG 2, 2018", "OCT 26, 2018", "JUL 16, 2018", "JUL 11, 2018", "JUN 15, 2018", "JUN 4, 2018", "MAY 22, 2018", "MAY 3, 2018", "MAR 28, 2018", "AUG 1, 2018", "FEB 28, 2018", "FEB 28, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 23, 2018", "JAN 19, 2018", "JAN 11, 2018", "MAR 6, 2018", "DEC 5, 2017", "NOV 30, 2017", "NOV 29, 2017", "NOV 27, 2017", "NOV 15, 2017", "NOV 10, 2017", "JAN 3, 2018", "OCT 31, 2017", "OCT 31, 2017", "OCT 27, 2017", "OCT 24, 2017", "SEP 20, 2017", "SEP 13, 2017", "SEP 6, 2017", "NOV 2, 2017", "JUL 31, 2017", "JUL 5, 2017", "JUN 21, 2017", "JUN 16, 2017", "JUN 16, 2017", "MAY 16, 2017", "MAY 4, 2017", "AUG 30, 2017", "JUL 31, 2017", "APR 27, 2017", "APR 27, 2017", "APR 21, 2017", "APR 20, 2017", "APR 20, 2017", "APR 20, 2017", "MAY 1, 2017", "APR 18, 2017", "APR 18, 2017", "APR 18, 2017", "APR 12, 2017", "APR 12, 2017", "APR 10, 2017", "APR 5, 2017", "APR 19, 2017", "APR 1, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 30, 2017", "MAR 28, 2017", "MAR 22, 2017", "MAR 21, 2017", "APR 4, 2017", "APR 1, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 30, 2017", "MAR 28, 2017", "MAR 22, 2017", "MAR 21, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 17, 2017", "MAR 10, 2017", "MAR 9, 2017", "MAR 9, 2017", "FEB 26, 2016", "DEC 19, 2016", "JAN 29, 2016", "JAN 27, 2016", "DEC 2, 2015", "NOV 6, 2015", "SEP 30, 2015", "SEP 16, 2015", "SEP 3, 2015", "FEB 18, 2016", "APR 1, 2015", "MAR 27, 2015", "MAR 12, 2015", "MAR 5, 2015", "JAN 20, 2015", "DEC 3, 2014", "SEP 23, 2014", "MAY 4, 2015", "AUG 25, 2014", "JUL 31, 2014", "JUL 31, 2014", "JUN 24, 2014", "JUN 5, 2014", "JUN 5, 2014", "JUN 4, 2014", "SEP 11, 2014", "AUG 25, 2014", "JUL 31, 2014", "JUL 31, 2014", "APR 15, 2014", "APR 14, 2014", "APR 11, 2014", "JUN 2, 2014", "JUN 2, 2014", "MAY 28, 2014", "MAY 22, 2014", "MAR 11, 2014", "MAR 4, 2014", "JAN 24, 2014", "JAN 23, 2014", "APR 10, 2014", "JAN 17, 2014", "JAN 13, 2014", "JAN 6, 2014", "NOV 20, 2013", "NOV 14, 2013", "NOV 14, 2013", "JAN 21, 2014", "JAN 21, 2014", "JAN 17, 2014", "JAN 13, 2014", "JAN 6, 2014", "SEP 3, 2013", "JUN 12, 2013", "NOV 11, 2013", "MAY 28, 2013", "MAY 8, 2013", "APR 4, 2013", "MAR 19, 2013", "NOV 1, 2012", "MAY 29, 2012", "MAY 9, 2012", "JUN 4, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/better-coronavirus-stock%3A-grifols-or-novartis-2020-06-19", "https://www.nasdaq.com/articles/who-can-donate-plasma-for-covid-19-patients-2020-06-14", "https://www.nasdaq.com/articles/7-pharmaceutical-stocks-to-buy-for-post-pandemic-gains-2020-06-09", "https://www.nasdaq.com/articles/bbhs-underlying-holdings-could-mean-11-gain-potential-2020-06-08", "https://www.nasdaq.com/articles/here-are-all-the-companies-working-on-covid-19-vaccines-treatments-and-testing-2020-04-07", "https://www.nasdaq.com/articles/analysts-anticipate-24-gains-ahead-for-the-holdings-of-bbh-2020-04-06", "https://www.nasdaq.com/articles/interesting-grfs-put-and-call-options-for-november-20th-2020-03-27", "https://www.nasdaq.com/articles/2-biotechs-battling-immune-diseases-2020-01-19", "https://www.nasdaq.com/articles/better-coronavirus-stock%3A-grifols-or-novartis-2020-06-19", "https://www.nasdaq.com/articles/is-rigel-pharmaceuticals-stock-a-buy-2019-12-11", "https://www.nasdaq.com/articles/grifols-s.a.-grfs-ex-dividend-date-scheduled-for-december-02-2019-2019-11-29", "https://www.nasdaq.com/articles/keep-an-eye-on-grfs-fivn-ingn...-2019-11-06", "https://www.nasdaq.com/articles/interesting-grfs-put-and-call-options-for-may-2020-2019-09-26", "https://www.nasdaq.com/articles/grifols-sa-barcelona-is-now-oversold-grfs-2019-09-09", "https://www.nasdaq.com/articles/interesting-grfs-put-and-call-options-for-september-20th-2019-07-23", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-05-2019%3A-tyme-cyad-grfs-jnj-pfe-abt-mrk-amgn-2019-07-05", "https://www.nasdaq.com/articles/heres-why-rigel-pharmaceuticals-is-erupting-this-week-2020-01-16", "https://www.nasdaq.com/articles/after-hours-most-active-apr-17-2019-veon-xog-vnet-grfs-qcom-intc-2019-04-17", "https://www.nasdaq.com/articles/european-adrs-move-lower-in-wednesday-trading-2019-04-10", "https://www.nasdaq.com/articles/heres-why-rigel-pharmaceuticals-gained-173-march-2019-04-10", "https://www.nasdaq.com/articles/european-adrs-move-higher-in-tuesday-trading-2019-04-09", "https://www.nasdaq.com/articles/heres-why-rigel-pharmaceuticals-gained-173-march-2019-04-09", "https://www.nasdaq.com/articles/european-adrs-move-higher-in-friday-trading-2019-03-29", "https://www.nasdaq.com/articles/european-adrs-move-lower-monday-trading-2019-03-25", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-22-2019%3A-enzholxgrfstnxpmbrxisrg-2019-04-22", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2019-02-07", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2019-01-17", "https://www.nasdaq.com/articles/european-adrs-move-sharply-higher-friday-trading-2019-01-04", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2018-12-06", "https://www.nasdaq.com/articles/european-adrs-move-higher-tuesday-trading-2018-11-13", "https://www.nasdaq.com/articles/after-hours-most-active-nov-6-2018-grfs-f-lho-fdc-rf-ge-qqq-bac-sbux-siri-nuan-comm-2018", "https://www.nasdaq.com/articles/european-adrs-move-higher-monday-trading-2018-10-29", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2019-03-07", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2019-02-07", "https://www.nasdaq.com/articles/grifols-grfs-surges%3A-stock-moves-5.4-higher-2018-10-12", "https://www.nasdaq.com/articles/european-adrs-edge-lower-thursday-trading-2018-10-11", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2018-10-04", "https://www.nasdaq.com/articles/european-adrs-move-higher-wednesday-trading-2018-10-03", "https://www.nasdaq.com/articles/is-grifols-s.a.-grfs-a-great-stock-for-value-investors-2018-09-17", "https://www.nasdaq.com/articles/european-adrs-move-lower-thursday-trading-2018-08-02", "https://www.nasdaq.com/articles/european-adrs-move-lower-friday-trading-2018-10-26", "https://www.nasdaq.com/articles/how-pieces-add-bbh-headed-146-2018-07-16", "https://www.nasdaq.com/articles/european-adrs-move-lower-wednesday-trading-2018-07-11", "https://www.nasdaq.com/articles/2-stable-and-2-speculative-biotech-stocks-buy-2018-06-15", "https://www.nasdaq.com/articles/european-adrs-move-higher-monday-trading-2018-06-04", "https://www.nasdaq.com/articles/3pea-payment-processor-40-organic-growth-selling-half-peer-multiples-2018-05-22", "https://www.nasdaq.com/articles/european-adrs-move-sharply-lower-thursday-trading-2018-05-03", "https://www.nasdaq.com/articles/european-adrs-move-higher-wednesday-trading-2018-03-28", "https://www.nasdaq.com/articles/european-adrs-move-lower-wednesday-trading-2018-08-01", "https://www.nasdaq.com/articles/grifols-sa-barcelona-grfs-shares-cross-below-200-dma-2018-02-28", "https://www.nasdaq.com/articles/european-adrs-move-higher-wednesday-trading-2018-02-28", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-novartis-2018-01-26", "https://www.nasdaq.com/articles/astrazeneca-gets-relative-strength-rating-upgrade-2018-01-26", "https://www.nasdaq.com/articles/stocks-showing-improving-market-leadership-grifols-earns-82-rs-rating-2018-01-23", "https://www.nasdaq.com/articles/fbt-nbix-grfs-ilmn-etf-inflow-alert-2018-01-19", "https://www.nasdaq.com/articles/earnings-season-watch-list-abbvie-2018-01-11", "https://www.nasdaq.com/articles/henry-schien-to-distribute-grifols-product-in-united-states-2018-03-06", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-joins-elite-club-stocks-rs-ratings-over-90-2017-12-05", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-shows-rising-price-performance-jump-83-rs-rating-2017-11-30", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-shows-rising-relative-price-performance-still-shy-key-threshold", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-earns-technical-rating-upgrade-2017-11-27", "https://www.nasdaq.com/articles/astrazeneca-getting-closer-key-technical-benchmark-2017-11-15", "https://www.nasdaq.com/articles/european-adrs-edge-lower-pharmaceutical-stocks-see-mixed-fortunes-2017-11-10", "https://www.nasdaq.com/articles/first-week-august-17th-options-trading-grifols-sa-2018-01-03", "https://www.nasdaq.com/articles/european-adrs-edge-higher-manufacturers-gain-traction-2017-10-31", "https://www.nasdaq.com/articles/stocks-showing-rising-market-leadership-grifols-earns-83-rs-rating-2017-10-31", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-astrazeneca-2017-10-27", "https://www.nasdaq.com/articles/gladstone-capital-management-llp-buys-match-group-inc-bank-new-york-mellon-corp-hertz-2017", "https://www.nasdaq.com/articles/should-value-investors-consider-grifols-grfs-stock-now-2017-09-20", "https://www.nasdaq.com/articles/3-pharma-biotech-sector-bargains-for-a-healthy-portfolio-2017-09-13", "https://www.nasdaq.com/articles/european-adrs-advance-pharma-stocks-see-mixed-fortunes-2017-09-06", "https://www.nasdaq.com/articles/european-adrs-edge-lower-miners-telecommunications-stocks-see-mixed-fortunes-2017-11-02", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-banks-see-mixed-fortunes-2017-07-31", "https://www.nasdaq.com/articles/gladstone-capital-management-llp-buys-activision-blizzard-inc-charter-communications-inc", "https://www.nasdaq.com/articles/interesting-grfs-put-and-call-options-february-2018-2017-06-21", "https://www.nasdaq.com/articles/european-adrs-move-higher-friday-trading-2017-06-16", "https://www.nasdaq.com/articles/should-value-investors-consider-grifols-grfs-stock-right-now-2017-06-16", "https://www.nasdaq.com/articles/tuesdays-etf-movers-vgk-ihf-2017-05-16", "https://www.nasdaq.com/articles/vivus-vvus-loss-narrower-than-expected-revenues-up-y-y-2017-05-04", "https://www.nasdaq.com/articles/european-adrs-move-lower-wednesday-trading-2017-08-30", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-banks-see-mixed-fortunes-2017-07-31", "https://www.nasdaq.com/articles/celgene-celg-tops-on-q1-earnings-sales-miss-raises-view-2017-04-27", "https://www.nasdaq.com/articles/glaxo-gsk-reports-in-line-q1-earnings-reiterates-view-2017-04-27", "https://www.nasdaq.com/articles/abbvie-abbv-presents-positive-data-on-hcv-combination-drug-2017-04-21", "https://www.nasdaq.com/articles/nivalis-nvls-shares-down-after-merger-deal-with-alpine-2017-04-20", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-arbor-realty-commercial-vehicle-group-grifols-s.a.-match", "https://www.nasdaq.com/articles/genocea-biosciences-gnca-catches-eye%3A-stock-gains-7.1-2017-04-20", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-banking-stocks-edge-forward-2017-05-01", "https://www.nasdaq.com/articles/amag-files-for-fda-approval-of-subcutaneous-form-of-makena-2017-04-18", "https://www.nasdaq.com/articles/ohr-pharmaceutical-ohrp-jumps%3A-stock-adds-15-in-session-2017-04-18", "https://www.nasdaq.com/articles/infinity-pharmaceuticals-infi-looks-good%3A-stock-jumps-19-2017-04-18", "https://www.nasdaq.com/articles/therapeuticsmd-falls-on-likely-delay-in-tx-004hr-approval-2017-04-12", "https://www.nasdaq.com/articles/wednesdays-etf-movers-fbt-xme-2017-04-12", "https://www.nasdaq.com/articles/galectin-therapeutics-galt-looks-good%3A-stock-jumps-16.7-2017-04-10", "https://www.nasdaq.com/articles/amgen-files-for-xgeva-label-expansion-to-include-myeloma-2017-04-05", "https://www.nasdaq.com/articles/how-uncover-institutional-buying-2017-04-19", "https://www.nasdaq.com/articles/new-breakout-stocks-zacks-rank-1-strong-buy-2017-04-01", "https://www.nasdaq.com/articles/european-adrs-edge-lower-pharmaceutical-stocks-see-mixed-fortunes-2017-03-31", "https://www.nasdaq.com/articles/abbvies-abbv-humira-drug-label-update-approved-by-fda-2017-03-31", "https://www.nasdaq.com/articles/new-strong-buy-stocks-march-30th-2017-03-30", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-jumps%3A-stock-gains-18.2-2017-03-28", "https://www.nasdaq.com/articles/5-cheap-peg-picks-for-value-investors-right-now-2017-03-22", "https://www.nasdaq.com/articles/allergans-dermal-filler-for-wrinkle-correction-gets-fda-nod-2017-03-21", "https://www.nasdaq.com/articles/sanofis-sny-diabetes-drug-toujeo-lowers-hypoglycemia-risk-2017-04-04", "https://www.nasdaq.com/articles/new-breakout-stocks-zacks-rank-1-strong-buy-2017-04-01", "https://www.nasdaq.com/articles/european-adrs-edge-lower-pharmaceutical-stocks-see-mixed-fortunes-2017-03-31", "https://www.nasdaq.com/articles/abbvies-abbv-humira-drug-label-update-approved-by-fda-2017-03-31", "https://www.nasdaq.com/articles/new-strong-buy-stocks-march-30th-2017-03-30", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-jumps%3A-stock-gains-18.2-2017-03-28", "https://www.nasdaq.com/articles/5-cheap-peg-picks-for-value-investors-right-now-2017-03-22", "https://www.nasdaq.com/articles/interesting-grfs-put-and-call-options-august-2017-2016-12-20", "https://www.nasdaq.com/articles/astrazeneca-azn-gets-another-crl-for-zs-9-inks-copd-deal-2017-03-20", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-health-care-stocks-see-mixed-fortunes-2017-03-20", "https://www.nasdaq.com/articles/is-grifols-a-great-stock-for-value-investors-2017-03-17", "https://www.nasdaq.com/articles/aurinia-auph-catches-eye%3A-stock-moves-up-8.5-in-session-2017-03-10", "https://www.nasdaq.com/articles/new-strong-buy-stocks-march-9th-2017-03-09", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-jumps%3A-stock-moves-up-8.6-2017-03-09", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-29-2016-vrx-endp-iep-nrg-hznp-trco-vgr-acad-grfs-bcpc", "https://www.nasdaq.com/articles/hologic-holx-to-divest-blood-screening-business-to-grifols-2016-12-19", "https://www.nasdaq.com/articles/european-adrs-advance-pharmaceutical-firms-strengthen-2016-01-29", "https://www.nasdaq.com/articles/fbt-crl-qgen-grfs-large-outflows-detected-etf-2016-01-27", "https://www.nasdaq.com/articles/pre-market-most-active-dec-2-2015-vale-yhoo-cpgx-abev-zfgn-sune-bac-xom-amsg-tvix-xiv-grfs", "https://www.nasdaq.com/articles/grifols-grfs%3A-moving-average-crossover-alert-2015-11-06", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-fbt-mygn-nktr-grfs-2015-09-30", "https://www.nasdaq.com/articles/grfs-makes-bullish-cross-above-critical-moving-average-2015-09-16", "https://www.nasdaq.com/articles/european-adrs-advance-mining-stocks-extend-gains-2015-09-03", "https://www.nasdaq.com/articles/first-trust-nyse-arca-biotechnology-index-fund-experiences-big-outflow-2016-02-18", "https://www.nasdaq.com/articles/european-adrs-gain-manufacturing-activity-rises-eurozone-2015-04-01", "https://www.nasdaq.com/articles/european-adrs-flat-pharma-gains-are-outweighed-mining-losses-2015-03-27", "https://www.nasdaq.com/articles/european-adrs-higher-oil-producers-and-pharma-stocks-rise-2015-03-12", "https://www.nasdaq.com/articles/european-adrs-trade-higher-eurozone-growth-forecast-rises-2015-03-05", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-tuesday-tale-of-the-tape-2015-01-20", "https://www.nasdaq.com/articles/grifols-sa-grfs-ex-dividend-date-scheduled-december-04-2014-2014-12-03", "https://www.nasdaq.com/articles/european-adrs-decline-dragged-down-oil-pharmaceuticals-2014-09-23", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-pharmaceuticals-stocks-gain-2015-05-04", "https://www.nasdaq.com/articles/grifols-grfs-shares-cross-above-200-dma-2014-08-25", "https://www.nasdaq.com/articles/markets-end-july-undecided-2014-07-31", "https://www.nasdaq.com/articles/grfs-crosses-below-key-moving-average-level-2014-07-31", "https://www.nasdaq.com/articles/weakness-seen-in-alcobra-adhd%3A-stock-falls-6.7-tale-of-the-tape-2014-06-24", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-06-05", "https://www.nasdaq.com/articles/positive-phase-iib-data-from-jazz-pharma-analyst-blog-2014-06-05", "https://www.nasdaq.com/articles/grifols-sa-grfs-ex-dividend-date-scheduled-june-05-2014-2014-06-04", "https://www.nasdaq.com/articles/european-adrs-pulled-down-contractions-pharmaceutical-stocks-2014-09-11", "https://www.nasdaq.com/articles/grifols-grfs-shares-cross-above-200-dma-2014-08-25", "https://www.nasdaq.com/articles/markets-end-july-undecided-2014-07-31", "https://www.nasdaq.com/articles/grfs-crosses-below-key-moving-average-level-2014-07-31", "https://www.nasdaq.com/articles/flamel-technologies-flml-in-focus%3A-stock-slumps-13.5-tale-of-the-tape-2014-04-15", "https://www.nasdaq.com/articles/pharmacyclics-pcyc-crumbles%3A-stock-falls-by-7.7-tale-of-the-tape-2014-04-14", "https://www.nasdaq.com/articles/pharmathene-pip-crumbles%3A-stock-falls-by-7.1-tale-of-the-tape-2014-04-11", "https://www.nasdaq.com/articles/patients-enrolled-in-avanir-study-analyst-blog-2014-06-02", "https://www.nasdaq.com/articles/pipeline-update-from-avanir-analyst-blog-2014-06-02", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-wednesday-tale-of-the-tape-2014-05-28", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-05-22", "https://www.nasdaq.com/articles/new-analyst-coverage-screen-week-2014-03-11", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-03-04", "https://www.nasdaq.com/articles/ariad-pharmaceuticals-aria-surges%3A-stock-moves-12.1-higher-tale-of-the-tape-2014-01-24", "https://www.nasdaq.com/articles/anacor-pharmaceuticals-anac-jumps%3A-stock-rises-9.4-tale-of-the-tape-2014-01-23", "https://www.nasdaq.com/articles/pacira-pharmaceuticals-pcrx-soars%3A-stock-adds-11.4-in-session-tale-of-the-tape-2014-04-10", "https://www.nasdaq.com/articles/would-you-fix-europe-real-time-insight-2014-01-17", "https://www.nasdaq.com/articles/can-grifols-grfs-stock-continue-to-grow-earnings-tale-of-the-tape-2014-01-13", "https://www.nasdaq.com/articles/flamel-technologies-sa-flml-jumps%3A-stock-adds-8.7-tale-of-the-tape-2014-01-06", "https://www.nasdaq.com/articles/john-paulsons-top-five-holdings-2013-11-20", "https://www.nasdaq.com/articles/pre-market-most-active-nov-14-2013-csco-kss-qqq-san-fb-alu-mfg-cdw-rdsb-siri-abx-grfs-2013", "https://www.nasdaq.com/articles/john-paulson-buys-vodafone-time-warner-cable-family-dollar-stores-sells-sprint-pioneer", "https://www.nasdaq.com/articles/forest-labs-impresses-earnings-beat-view-analyst-blog-2014-01-21", "https://www.nasdaq.com/articles/ariads-iclusig-returns-to-u.s.-analyst-blog-2014-01-21", "https://www.nasdaq.com/articles/would-you-fix-europe-real-time-insight-2014-01-17", "https://www.nasdaq.com/articles/can-grifols-grfs-stock-continue-to-grow-earnings-tale-of-the-tape-2014-01-13", "https://www.nasdaq.com/articles/flamel-technologies-sa-flml-jumps%3A-stock-adds-8.7-tale-of-the-tape-2014-01-06", "https://www.nasdaq.com/articles/aradigm-grifols-collaborate-analyst-blog-2013-09-03", "https://www.nasdaq.com/articles/pre-market-most-active-jun-12-2013-ctb-nct-wday-bac-vod-s-nok-gt-grfs-arna-siri-clvs-2013", "https://www.nasdaq.com/articles/mid-day-market-update-gogo-jumps-upbeat-results-8x8-shares-tumble-2013-11-11", "https://www.nasdaq.com/articles/grifols-sa-grfs-ex-dividend-date-scheduled-may-29-2013-2013-05-28", "https://www.nasdaq.com/articles/after-hours-most-active-may-8-2013-mac-qqq-grpn-mrk-gmcr-ddd-mu-cor-grfs-etp-cx-gt-2013-05", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-thursday-tale-of-the-tape-2013-04-04", "https://www.nasdaq.com/articles/pre-market-most-active-mar-19-2013-bac-nok-eric-two-chl-grfs-lulu-hpt-siri-dell-hnr-qqq", "https://www.nasdaq.com/articles/pre-market-most-active-nov-1-2012-jdas-siri-bac-nok-cbb-sny-phg-grfs-pfe-aapl-asml-qqq", "https://www.nasdaq.com/articles/pre-market-most-active-may-29-2012-vrtx-bac-nok-lcry-fb-gnom-std-bhp-grfs-amrn-bud-c-2012", "https://www.nasdaq.com/articles/pre-market-most-active-may-9-2012-bac-arna-armh-nok-soda-grfs-qqq-rdsb-ihg-f-c-ktos-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-4-2013-et-ing-nok-znga-asml-bac-ubs-mtu-rigl-grfs-qqq-infi-2013"], "Content": []}